The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Results of a phase 1/2 study of MHB088C: A novel B7H3 antibody-drug conjugate (ADC) incorporating a potent DNA topoisomerase I inhibitor in recurrent or metastatic solid tumors.
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; MSD; SERVIER; Transcenta Holding Limited
Research Funding - BeiGene (Inst)
 
Caicun Zhou
No Relationships to Disclose
 
Xue Meng
No Relationships to Disclose
 
Yuping Sun
Honoraria - AstraZeneca; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Roche
Research Funding - Pfizer; Roche
 
Yinghua Ji
Research Funding - AoSaiKang (Inst); CSPC Pharmaceutical Group (Inst); Hualan Bio (Inst)
 
Haihua Yang
No Relationships to Disclose
 
Fangling Ning
No Relationships to Disclose
 
Liang Han
No Relationships to Disclose
 
Ou Jiang
No Relationships to Disclose
 
Meili Sun
No Relationships to Disclose
 
Qing Wen
No Relationships to Disclose
 
Xinmin Yu
No Relationships to Disclose
 
Yuming Jia
No Relationships to Disclose
 
Hai Huang
No Relationships to Disclose
 
Yanqiu Zhao
No Relationships to Disclose
 
Zhiye Zhang
No Relationships to Disclose
 
Chuntao Tian
No Relationships to Disclose
 
Zhen Zhang
No Relationships to Disclose
 
Junwei Shi
Employment - Minghui Pharmaceutical
Stock and Other Ownership Interests - Minghui Pharmaceutical
Patents, Royalties, Other Intellectual Property - Minghui Pharmaceutical
 
Guoqing Cao
Employment - Minghui Pharmaceutical
Leadership - Minghui Pharmaceutical
Stock and Other Ownership Interests - Minghui Pharmaceutical
Patents, Royalties, Other Intellectual Property - Minghui Pharmaceutical